Cryosite
Cryosite Limited (ASX: CTE) is an Australian TGA-licensed clinical trial depot services provider offering multi-temperature storage, distribution, secondary packaging, and importer of record services to pharmaceutical companies, CROs, and biotechnology firms from its Sydney facility, with specialization in cryogenic storage for cell and gene therapies.
- Company typePublic
- Founded2000
- HeadquartersGranville, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Cryosite does
Cryosite Limited (ASX: CTE) is an Australian clinical trial depot services provider operating from a TGA-licensed, GMP-certified facility in South Granville, NSW. The company manages the end-to-end clinical trial supply chain for pharmaceutical companies, contract research organisations (CROs), and biotechnology firms, including importation of clinical materials, multi-temperature storage (controlled ambient 15–25°C, refrigerated 2–8°C, frozen -20°C, ultra-frozen -80°C, and cryogenic -196°C), distribution, secondary packaging, and reverse logistics including drug return and destruction. Cryosite operates one of Australia's largest single-site liquid nitrogen tank farms for cryogenic storage of cell and gene therapies, biological samples, and cell banks, supported by validated Warehouse Management and Quality Management Systems, 24/7 continuous temperature monitoring with automated alarm escalation, and RF barcode scanning for full chain-of-custody traceability. The company also retains a legacy cord blood storage portfolio from its origins as Australia's first private cord blood bank in 2000, including samples acquired from StemLife in 2016, though new cord blood collections ceased in 2017.
Cryosite generates revenue through managed-services contracts for clinical trial depot services and biological storage, supplemented by professional-services fees for importer of record work and TGA-licensed secondary packaging. Pricing is quote-based and tailored to client specifications rather than published on a tiered schedule. The company manages more than 6,000 shipments annually with a 99% on-time delivery rate and 90% temperature-controlled shipments, distributing across Australia, Asia Pacific, America, and Europe via carrier partnerships. Reported FY2026 unaudited financials show revenue of A$16.7 million and EBITDA of A$4.3 million, indicating profitable operations on a specialized-services base with a small headcount (11–50 employees).
The business is differentiated by a deep regulatory credential stack — TGA license, cGMP, PIC/S GMP, NSW Health wholesaler licensing, Department of Agriculture Approved Arrangement, and Australian cGMP for human blood, tissues, and cell therapies — which collectively raise barriers to entry for would-be depot competitors in the Australian market. Cryosite's go-to-market relies on direct B2B enterprise sales to pharma sponsors and CROs, supplemented by content marketing and industry association partnerships with ARCS and AusBiotech.
Cryosite firmographics
Firmographics- Name
- Cryosite
- Legal name
- Cryosite Limited
- Website
- https://cryosite.com
- Company type
- Public
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cryosite Limited (ASX: CTE) is an Australian TGA-licensed clinical trial depot services provider offering multi-temperature storage, distribution, secondary packaging, and importer of record services to pharmaceutical companies, CROs, and biotechnology firms from its Sydney facility, with specialization in cryogenic storage for cell and gene therapies.
- Ownership category
- akta.pro rank
Cryosite industry classification
Industry- Product category
- Clinical Trial Logistics Services
- NAICS
- Refrigerated Warehousing and Storage (493120)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trials & Investigational Product (IP) Cold Chain Logistics (TLAIAIAC)
- akta.pro secondary industries
- Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN), Cryogenic / Ultra-Low Temperature Transport (e.g., dry ice, LN2) (TLADAHAJ), Dry Ice & Cryogenic (LN2) Handling and Transport Services (TLACAMAM)
Keywords
Where Cryosite is headquartered
LocationHeadquarters
- HQ city
- Granville
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Cryosite business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Trial Depot Services: Outsourced clinical trial logistics services including storage, distribution, returns management, and destruction of investigational products
- Biological Storage Services: Cold, frozen, and cryogenic storage for biological materials including cord blood, cell banks, and tissue samples
- Importer of Record Services: Legal importation of clinical materials into Australia with permit applications support
- Secondary Packaging Services: TGA-licensed packaging services including re-labelling, re-packaging, and expiry extension
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Cryosite product offering
Product offeringCore offering
Cryosite provides outsourced clinical trial depot services and biological storage from its TGA-licensed, GMP-certified facility in Sydney, Australia. The company manages the full clinical trial supply chain including importation, receipt, multi-temperature storage (controlled ambient, refrigerated, frozen, ultra-frozen, and cryogenic at -196°C), distribution, secondary packaging, and reverse logistics for pharmaceutical companies, CROs, and biotechnology firms. Additional services include cryogenic storage for cell and gene therapies, importer of record services, and drug return and destruction.
Product overview
Cryosite is a clinical trials depot services company operating as a specialized third-party logistics (3PL) provider for the life sciences and biotechnology industries. The company offers a unified portfolio of services centered around clinical trial supply chain management, encompassing clinical trial logistics, biological storage (including cryogenic liquid nitrogen storage), cell and gene therapies depot services, cold chain management, temperature-sensitive distribution, and secondary packaging. Additional services include importer of record, drug return & destruction, and legacy cord blood storage. The company operates from a TGA-licensed and GMP-certified facility in Sydney, Australia, managing over 6,000 shipments annually with 90% temperature-controlled.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Logistics Services Specialised outsourced clinical trial logistics services managing the entire clinical trial supply chain from importation, receipt, ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, to distribution and reverse logistics management. Targeted at pharmaceutical companies, CROs, and biotechnology firms.
- Biological Storage Frozen storage services for biological materials including cell banks (MCB, WCB), mesenchymal stromal cell therapies, TIL therapies, HPC therapies, vaccines, tissue samples, and blood products at various temperature ranges from -25°C to -196°C. For biotechnology and pharmaceutical companies.
- Cell & Gene Therapies Depot Services Depot services specifically designed for cell and gene therapies, providing cryogenic storage, chain of custody management, and logistics support for these advanced therapeutic modalities. Targeted at biotechnology companies developing advanced therapies.
- Liquid Nitrogen Storage Cryogenic liquid nitrogen storage solutions maintaining temperatures at -196°C for preserving biological materials, cell and gene therapies, with advanced cryogenic monitoring technology. For pharmaceutical, biotech, and research organisations.
- Importer of Record Services Expert importer of record services ensuring legal importation of clinical materials into Australia, including permit applications for Office of Drug Control, Australian Biosecurity Import Conditions, and Department of Gene Technology Regulator. For pharmaceutical companies and CROs importing clinical materials.
- Secondary Packaging TGA-licensed clinical trial packaging services including over-labelling, expiry extension, package insert management, re-packaging, bundling and kitting to GMP standards. For pharmaceutical companies conducting clinical trials.
- Cold Chain Management End-to-end cold chain management solutions for investigational medicinal products including temperature-controlled storage, validated freezer storage containers, liquid nitrogen storage, and temperature monitoring for full compliance and traceability. For pharmaceutical and biotech companies.
- Time & Temperature Sensitive Distribution Temperature-controlled logistics and distribution services maintaining specific temperature ranges (controlled ambient 15-25°C, refrigerated 2-8°C, frozen -20°C, dry ice -80°C, cryogenic LN2) during transport across Australia, Asia Pacific, America and Europe. For pharmaceutical companies, CROs, and biotech firms.
- Drug Return & Destruction Reverse logistics services managing collection of unused medication from supply chain points including patients and investigator sites, with cold chain maintenance during collection and proper destruction of controlled medicines with Certificate of Destruction. For pharmaceutical companies managing clinical trial returns.
- Pharmaceutical Storage Secure and temperature-controlled pharmaceutical storage including controlled ambient (15-25°C) and security vault storage for highly regulated, temperature-sensitive products. For pharmaceutical companies and biotech firms.
Quantifiable outcome
- 99% on-time delivery for shipments
- +2 more outcomes
Companies that use Cryosite
Customer profileSegments4 records
Ideal customer profiles3 records
Cryosite technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Cryosite partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- ARCSminorARCS (Australia) is listed as a partner organization on Cryosite's website. ARCS is an industry association for clinical research.
- AusBiotechminorAusBiotech is listed as a partner organization on Cryosite's website. AusBiotech is Australia's biotechnology industry organization.
- StemLifeminorCryosite acquired StemLife cord blood samples in 2016 and continues to store these samples long-term at their facility.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Cryosite competitors and assessment
Company assessmentDirect peers
- Biocair: Biocair is a specialist life sciences logistics provider focused on clinical trial and pharmaceutical cold-chain distribution with strong APAC and global reach — directly comparable to Cryosite's clinical trial logistics and cold-chain services.
- World Courier: World Courier (part of Cencora/AmerisourceBergen) provides specialty pharmaceutical logistics including clinical trial storage, distribution, and cold-chain management — a direct competitor to Cryosite in clinical trial depot services with a globally larger depot network.
- Azenta Life Sciences: Azenta (formerly Brooks Life Sciences/BioStorage Technologies) operates biological sample storage, cryogenic storage, and biorepository services globally — a direct peer to Cryosite's biological and cryogenic storage business, with significantly larger global scale.
- Cryoport Systems: Cryoport provides temperature-controlled logistics and cryogenic shipping (LN2/vapor phase) for the life sciences industry, including cell and gene therapy supply chains — directly comparable to Cryosite's cryogenic storage and CGT depot services, with global scope and broader service portfolio.
- Marken: Marken (a UPS company) is a global clinical trial logistics specialist offering time- and temperature-sensitive supply chain services, cold-chain storage, and direct-to-patient distribution — directly comparable to Cryosite's core clinical trial depot and cold-chain business, with a larger global footprint.
Broad incumbents
- Almac Group: Almac Group provides integrated clinical trial supply services including packaging, distribution, and temperature-controlled storage as part of a broader pharmaceutical services portfolio — overlapping with Cryosite's secondary packaging and depot offerings but at a larger scale and broader scope.
- DHL Supply Chain (Life Sciences): DHL Supply Chain operates dedicated life sciences and clinical trial logistics networks with global cold-chain warehousing and GDP-compliant distribution — competing with Cryosite's clinical trial depot and cold-chain services as part of DHL's much broader logistics portfolio.
- Clario (formerly Bioclinica): Clario provides clinical trial technology and supporting services including temperature monitoring and clinical logistics — competing with Cryosite in clinical trial depot and cold-chain monitoring services as part of a broader eClinical platform.
- Eurofins BioPharma Product Testing: Eurofins operates a global bioanalytical and biopharma services network that includes sample handling, storage, and cold-chain logistics — an adjacent competitor with overlapping biological sample storage capabilities though primarily focused on testing rather than depot services.
Emerging players
- Cell&Co BioServices: Cell&Co provides bioservices including cell banking, biological sample storage, and cryopreservation services for biotech and cell therapy companies — a niche, emerging peer with overlapping biological and cryogenic storage capabilities to Cryosite.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Cryosite social profiles
Digital presenceCryosite compliance and trust
Trust signalCompliance8 records
Cryosite financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cryosite leadership team
Management profileNumber of profiles
Profiles4 records
Cryosite subsidiaries and ownership
Company hierarchySubsidiaries1 record
Cryosite funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cryosite M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cryosite
What does Cryosite do?
Cryosite provides outsourced clinical trial depot services and biological storage from its TGA-licensed, GMP-certified facility in Sydney, Australia. The company manages the full clinical trial supply chain including importation, receipt, multi-temperature storage (controlled ambient, refrigerated, frozen, ultra-frozen, and cryogenic at -196°C), distribution, secondary packaging, and reverse logistics for pharmaceutical companies, CROs, and biotechnology firms. Additional services include cryogenic storage for cell and gene therapies, importer of record services, and drug return and destruction.
Is Cryosite a public or private company?
Cryosite is a public company. It is classified as public and is currently operating.
When was Cryosite founded?
Cryosite was founded in 2000. It employs 11 to 50 people.
Where is Cryosite based?
Cryosite is headquartered in Granville, Australia, in the Oceania region.
How does Cryosite make money?
Four revenue lines are on record. Clinical Trial Depot Services are the primary driver. The others are biological Storage Services, importer of Record Services and secondary Packaging Services.
Who are Cryosite's main competitors?
Direct peers on record are Biocair, World Courier, Azenta Life Sciences, Cryoport Systems and Marken. Broad incumbents are Almac Group, DHL Supply Chain (Life Sciences), Clario (formerly Bioclinica) and Eurofins BioPharma Product Testing. Cell&Co BioServices is listed as an emerging player.
Does Cryosite have an API?
No public API is recorded for Cryosite.
What industry is Cryosite in?
Cryosite's product category is Clinical Trial Logistics Services. Its primary akta.pro industry code is TLAIAIAC, Clinical Trials & Investigational Product (IP) Cold Chain Logistics, with a secondary code of HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low). Its NAICS code is 493120 and its SIC code is 5047.